ResMed (NYSE:RMD) reported quarterly earnings of $2.86 per share which beat the analyst consensus estimate of $2.80 by 2.14 percent. This is a 20.68 percent increase over earnings of $2.37 per share from the same period last year. The company reported quarterly sales of $1.431 billion which beat the analyst consensus estimate of $1.419 billion by 0.83 percent. This is a 10.76 percent increase over sales of $1.292 billion the same period last year.